Patient dosing completed in Phase 2 portion of Phase 2/3 RePOSA study evaluating IHL-42X oral treatment…
Continue ReadingTag: OSA
New FDA-Cleared NightOwl Home Sleep Test Revolutionizes OSA Diagnosis
Resmed (NYSE: RMD) has announced the nationwide U.S.…
Continue Reading
Celebrating World Sleep Day across specialties: OSA ‘touches every organ’
March 13, 2025 19 min read Add topic to email alerts Receive an email when new…
Continue Reading
Greater positive airway pressure adherence in OSA yields lower health care costs
December 18, 2023 4 min read Add topic to email alerts …
Continue Reading